Retinol-Binding Protein 4 in Human Obesity

Studies in mice suggest that adipocytes serve as glucose sensors and regulate systemic glucose metabolism through release of serum retinol-binding protein 4 (RBP4). This model has not been validated in humans. RBP4 was highly expressed in isolated mature human adipocytes and secreted by differentiating human adipocytes. In contrast to the animal data, RBP4 mRNA was downregulated in subcutaneous adipose tissue of obese women, and circulating RBP4 concentrations were similar in normal weight, overweight, and obese women (n = 74). RBP4 was positively correlated with GLUT4 expression in adipose tissue, independent of any obesity-associated variable. Five percent weight loss slightly decreased adipose RBP4 expression but did not influence circulating RBP4. In another set of experiments, we stratified patients (n = 14) by low or high basal fasting interstitial glucose concentrations, as determined by the microdialysis technique. Venous glucose concentrations were similar throughout oral glucose tolerance testing, and basal RBP4 expression in adipose tissue and serum RBP4 concentrations were similar in the groups with higher and lower interstitial glucose levels. Our findings point to profound differences between rodents and humans in the regulation of adipose or circulating RBP4 and challenge the notion that glucose uptake by adipocytes has a dominant role in the regulation of RBP4.

[1]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[2]  M. Esler,et al.  Interactions Between Leptin and the Human Sympathetic Nervous System , 2003, Hypertension.

[3]  J. Dickerson,et al.  Retinol, alpha-tocopherol and carotenoids in diabetes. , 1999, European journal of clinical nutrition.

[4]  G. Malpeli,et al.  Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin. , 1996, Biochimica et biophysica acta.

[5]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[6]  J. Dickerson,et al.  Retinol, α-tocopherol and carotenoids in diabetes , 1999, European Journal of Clinical Nutrition.

[7]  R. Busse,et al.  Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.

[8]  R. Wolf Task Force on Developing Obesity Outcomes and Learning Standards (TOOLS). Proceedings of a symposium. Warrenton, Virginia, USA. June 11-13, 1999. , 2002, Obesity research.

[9]  W. Blaner Retinol-binding protein: the serum transport protein for vitamin A. , 1989, Endocrine reviews.

[10]  W. Blaner,et al.  Differentiation-dependent expression of retinoid-binding proteins in BFC-1 beta adipocytes. , 1992, The Journal of biological chemistry.

[11]  S. Rössner,et al.  Insulin signal transduction and glucose transport in human adipocytes: effects of obesity and low calorie diet , 2002, Diabetologia.

[12]  E. E. Wein,et al.  Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Nutrition.

[13]  Arya M. Sharma,et al.  Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. , 2002, Diabetes.

[14]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[15]  A. Fukamizu,et al.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  P. Froguel,et al.  Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.

[17]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[18]  O. Ezaki,et al.  Role of Two Types of Glucose Transporters in Enlarged Adipocytes From Aged Obese Rats , 1990, Diabetes.

[19]  Arya M. Sharma,et al.  Adipose Tissue Metabolism and CD11b Expression on Monocytes in Obese Hypertensives , 2005, Hypertension.

[20]  G. Shulman,et al.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.

[21]  Arya M. Sharma,et al.  Association between adiponectin and mediators of inflammation in obese women. , 2003, Diabetes.

[22]  Arya M. Sharma,et al.  Weight Loss and the Renin-Angiotensin-Aldosterone System , 2005, Hypertension.

[23]  M. Birnbaum Diabetes: Dialogue between muscle and fat , 2001, Nature.

[24]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[25]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[26]  A. Mark,et al.  Role of selective leptin resistance in diet-induced obesity hypertension. , 2005, Diabetes.

[27]  Arya M. Sharma,et al.  Resistin gene expression in human adipocytes is not related to insulin resistance. , 2002, Obesity research.

[28]  J. Bolinder,et al.  Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[29]  R. Bonnichsen Ethanol: Determination with Alcohol Dehydrogenase and DPN , 1965 .

[30]  C. Sigman,et al.  Fenretinide: a prototype cancer prevention drug , 2003, Expert opinion on investigational drugs.

[31]  M. Allan,et al.  Retinoids and retinoid-binding protein expression in rat adipocytes. , 1992, The Journal of biological chemistry.

[32]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .